Prevalence and outcomes of pulmonary arterial hypertension in advanced idiopathic pulmonary fibrosis.

By C. Lettieri, S. Nathan, S. Barnett, Shahzad Ahmad, A. Shorr. Chest, 2006

839 citations recorded by the source corpus.

Subfields: Pulmonary and Respiratory Medicine, Surgery

View Paper: https://www.semanticscholar.org/paper/75ed9915cb6aa4e40cc4bd407be8335b52f09559

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Pulmonary and Respiratory Medicine

1. H. Collard
2. B. Ley
3. G. Raghu
4. T. King

Citations in the corpus

• Clinical course and prediction of survival in idiopathic pulmonary fibrosis. (2011, background): “Other clinical parameters may be useful in selecting patients with higher pretest probability for having pulmonary hypertension in IPF, including reduced DLCO, use of supplemental oxygen, and poor performance on 6MWT (58).”
• Interstitial lung disease guideline (2008, neutral): “составила 28 %, по сравнению с 5,5 % среди 70 пациентов с нормальным ДЛА [629, 643].”
• An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline: Treatment of Idiopathic Pulmonary Fibrosis. An Update of the 2011 Clinical Practice Guideline. (2015, background): “Comorbid PH is commonly seen in patients with IPF and contributes to a worsened clinical prognosis (63, 64).”